Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients

Abstract

ADL-ability is the most important predictor of societal costs of care in community dwellings irrespective of country and should therefore be central in the economic evaluation of Alzheimer's disease therapies.